Skip to main content

Events

Core Facilities Brown Bag

February 5th, 2024
Zoom Presentation

Notes

Procurement Standards 2024

NSPM-33

  1. Capital Equipment Bid Documentation/Sole Source Procedure Update w/ Jim Konrad- starts at 0:20
  2. NSPM-33/DFAR (Cyber Security) Updates w/ Brandon Grill, Amy Weber, and Paul Hinds- starts at 24:54
    1. Reach out to exportcontrols@northwestern.edu with questions
  3. FY24 Annual Report/FY25 Operations Request w/ Andy Ott and Jeff Weiss- starts at 44:34
  4. NUcore Update: Duration Based Billing w/ Lin- starts at 50:31
  5. ABRF Membership- starts at 48:51

 

November 6th, 2023
Zoom Presentation

Notes

  1. Updates on OR Org Structure- starts at 4:33
  2. Usage Trends- starts at 5:52
  3. Professional Development- starts at 7:15
    1. ABRF announcement to come out at a future date
  4. UBI Updates- starts at 13:41
    1.  Timeline
    2. Fully costed rate update
  5. NUcore Updates- starts at 19:19 and 39:06 
    1. New Features: email Linda Lewandosky with your questions
  6. Internal Grants Update- starts at 34:36 
    1. Expect an email for the Spring competition to be sent out soon
  7. User Survey Trends- starts at 50:54

 

August 7th, 2023
Zoom Presentation

  1. Updates on OR Org Structure- starts at 2:35
    Office for Research Website
  2. Prep for Year End with Key Dates- starts at 11:45
  3. Other Key Dates- starts at 17:54
  4. NUcore Updates- starts at 23:05

CLP Faculty Chalk Talk

January 19, 2022

Imaging Gene Delivery by MRI: Where Seeing is Really Believing

poster for sessionWith a mean survival rate of 5 years, lysomal storage diseases (LSD) are among the most devastating. LSDs represent a large number of monogenetic diseases, such as hemophilia, Tay-Sachs disease, sickle cell disease and cystic fibrosis.

The transformative results documented in an adeno-associated virus (AAV) gene therapy clinical trial in infants affected by spinal muscular atrophy demonstrated unequivocally, the potential of in vivo gene transfer to treat monogenic neurological disorder.

To date there is a lack of non-invasive ways to determine biodistribution or activity levels of these AAV therapies in patients. This is a significant hinderance, leaving investigators guessing which organs or structures are effectively treated and, due to the lag time associated with clinical disease progression, this limitation ultimately impacts the evolution of treatment modalities.

In order to overcome these limitations, Meade’s lab is developing a new class of bioresponsive magnetic resonance imaging probes to track enzymatic activity in any organ, peripheral nervous system, or central nervous system over time.


michael_vincent photoRising Stars of SQI Lecture – 07/28/21

Sponsored by the Peptide Synthesis Core and ANTE

Featuring Michael Vincent, PhD, Evan Scott Laboratory, who will present a lecture titled “Controlling Interactions at the Nano-Bio Interface to Enhance Drug Delivery Vehicle Performance”

Wednesday, July 28, 2021, 2-3 PM

Simpson Querrey Auditorium, Simpson Querrey Biomedical Research Center
303 E Superior St, Chicago, IL


sqilecture.jpgRising Stars of SQI Lecture – 02/04/21

Sponsored by the Peptide Synthesis Core and ANTE

Featuring Tristan Clemons, PhD, Stupp Laboratory, who will present a lecture titled Superstructured Biomaterials Formed by Host-Guest Interactions in Supramolecular Polymers.

Thursday, February 4, 2021, 2-3 PM